Squalene epoxidase promotes pancreatic ductal adenocarcinoma tumorigenesis and drives gemcitabine resistance by activating the PI3K-Akt pathway

被引：0
|
作者：
Liu, Lei [1 ]
Xu, Hui [2 ]
Huang, Xinyang [1 ]
Li, Weilin [3 ]
Jin, Yixun [1 ]
Zhang, Minmin [1 ]
Wang, Lifu [1 ]
Zou, Duowu [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Shanghai, Peoples R China
[2] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Hangzhou, Zhejiang, Peoples R China
[3] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USA
来源：
GUT | 2023年 / 72卷 / SUPPL_1期
关键词：
D O I：
10.1136/gutjnl-2023-IDDF.68
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
IDDF2023-A
引用
收藏
页码：A76 / A77
页数：2
相关论文
共 50 条
  • [1] Agmatinase promotes the lung adenocarcinoma tumorigenesis by activating the NO-MAPKs-PI3K/Akt pathway
    Zhu, Hui-er
    Yin, Jia-yi
    Chen, De-xiong
    He, Sheng
    Chen, Hui
    CELL DEATH & DISEASE, 2019, 10 (11)
  • [2] Agmatinase promotes the lung adenocarcinoma tumorigenesis by activating the NO-MAPKs-PI3K/Akt pathway
    Hui-er Zhu
    Jia-yi Yin
    De-xiong Chen
    Sheng He
    Hui Chen
    Cell Death & Disease, 10
  • [3] Squalene epoxidase promotes pancreatic cancer growth by attenuating ER stress and activating lipid rafts-regulated Src/PI3K/Akt signalling pathway
    Xu, R.
    Song, J.
    Ruzi, R.
    Chen, Y.
    Yin, X.
    Wang, C.
    Zhao, Y.
    ANNALS OF ONCOLOGY, 2023, 34 : S914 - S914
  • [4] MLPH regulates EMT in pancreatic adenocarcinoma through the PI3K-AKT signaling pathway
    Wei, Mengda
    Yang, Xi
    Yang, Xiaoying
    Huang, Yanqing
    Yuan, Zhenmin
    Huang, Junjie
    Wei, Junren
    Tian, Lei
    JOURNAL OF CANCER, 2024, 15 (17): : 5828 - 5838
  • [5] Linc-ROR promotes endometrial cell proliferation by activating the PI3K-Akt pathway
    Xu, X-Y
    Zhang, J.
    Qi, Y-H
    Kong, M.
    Liu, S. A.
    Hu, J-J
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (08) : 2218 - 2225
  • [6] Berberine Overcomes Gemcitabine-Associated Chemoresistance through Regulation of Rap1/PI3K-Akt Signaling in Pancreatic Ductal Adenocarcinoma
    Okuno, Keisuke
    Xu, Caiming
    Pascual-Sabater, Silvia
    Tokunaga, Masanori
    Han, Haiyong
    Fillat, Cristina
    Kinugasa, Yusuke
    Goel, Ajay
    PHARMACEUTICALS, 2022, 15 (10)
  • [7] Cotargeting of Epidermal Growth Factor Receptor and PI3K Overcomes PI3K-Akt Oncogenic Dependence in Pancreatic Ductal Adenocarcinoma
    Wong, Matthew H.
    Xue, Aiqun
    Julovi, Sohel M.
    Pavlakis, Nick
    Samra, Jaswinder S.
    Hugh, Thomas J.
    Gill, Anthony J.
    Peters, Lyndsay
    Baxter, Robert C.
    Smith, Ross C.
    CLINICAL CANCER RESEARCH, 2014, 20 (15) : 4047 - 4058
  • [8] KNSTRN promotes tumorigenesis and gemcitabine resistance by activating AKT in bladder cancer
    Xiong, Yaoyi
    Ju, Lingao
    Yuan, Lushun
    Chen, Liang
    Wang, Gang
    Xu, Huimin
    Peng, Tianchen
    Luo, Yongwen
    Xiao, Yu
    Wang, Xinghuan
    ONCOGENE, 2021, 40 (09) : 1595 - 1608
  • [9] KNSTRN promotes tumorigenesis and gemcitabine resistance by activating AKT in bladder cancer
    Yaoyi Xiong
    Lingao Ju
    Lushun Yuan
    Liang Chen
    Gang Wang
    Huimin Xu
    Tianchen Peng
    Yongwen Luo
    Yu Xiao
    Xinghuan Wang
    Oncogene, 2021, 40 : 1595 - 1608
  • [10] HIF-1α-regulated stanniocalcin-1 mediates gemcitabine resistance in pancreatic ductal adenocarcinoma via PI3K/AKT signaling pathway
    Zhao, Fangyu
    Yang, Gang
    Qiu, Jiangdong
    Liu, Yueze
    Tao, Jinxin
    Chen, Guangyu
    Su, Dan
    You, Lei
    Zheng, Lianfang
    Zhang, Taiping
    Zhao, Yupei
    MOLECULAR CARCINOGENESIS, 2022, 61 (09) : 839 - 850
12345